Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

By Yonemori Kan   Katsumata Noriyuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Tokunaga Shinya   Yamanaka Yasuhiro   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 237-241

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Tolerance of Vinorelbine in Elderly Patients with Metastatic Breast Cancer

By Sorio R.   Robieux I.   Galligioni E.   Freschi A.   Colussi A.M.   Crivellari D.   Saracchini S.   Monfardini S.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 301-303

Elsevier

Access to resources Recommend Favorite

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients

By Henningsson A.   Sparreboom A.   Sandstrom M.   Freijs A.   Larsson R.   Bergh J.   Nygren P.   Karlsson M.O.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1105-1114

Elsevier

Access to resources Recommend Favorite

Phase I Study with a Weekly 1 h Infusion of Paclitaxel in Heavily Pretreated Patients with Metastatic Breast and Ovarian Cancer

By Klaassen U.   Wilke H.   Strumberg D.   Eberhardt W.   Korn M.   Seeber S.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 547-549

Elsevier

Access to resources Recommend Favorite

HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 277-278

Informa Healthcare

Access to resources Recommend Favorite